Increasing timely newborn hepatitis B vaccination in Nigeria
Research Project 2
This project uses crowdsourced community ideas to increase timely hepatitis B vaccine given within 24 hours to newborns in Nigerian communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11411620 on NIH RePORTER |
What this research studies
As a parent or community member in Nigeria, this project invites people to submit ideas that could encourage new mothers and birth attendants to give the hepatitis B birth dose within 24 hours. Researchers will pick promising solutions from the crowd and implement them at community clinics, during home births, and other non-hospital birth settings. They will use implementation science tools (CFIR) and concept mapping to adapt and organize the approaches for local use and track whether more babies get vaccinated on time. The work is focused on practical, community-driven strategies to raise HepB-BD coverage and prevent hepatitis B infections and future liver cancer.
Who could benefit from this research
Good fit: Ideal candidates are newborns and their mothers in the Nigerian communities targeted by the project, especially babies born at home or at community clinics who can receive a HepB birth dose within 24 hours.
Not a fit: People outside the selected Nigerian communities, adults without newborns, or infants who already receive a timely HepB birth dose are unlikely to directly benefit from this project.
Why it matters
Potential benefit: If successful, more newborns would receive the birth-dose hepatitis B vaccine on time, reducing newborn HBV infections and lowering future risk of liver cancer.
How similar studies have performed: Similar crowdsourcing approaches have improved hepatitis testing messages and community engagement in low-resource settings, but applying crowdsourcing to increase birth-dose vaccination is relatively new.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.